key: cord-0994439-32bsrr18
authors: Bruyndonckx, Robin; Coenen, Samuel; Butler, Chris; Verheij, Theo; Little, Paul; Hens, Niel; Beutels, Philippe; Ieven, Margareta; Goossens, Herman
title: Respiratory syncytial virus and influenza virus infection in adult primary care patients: association of age with prevalence, diagnostic features and illness course
date: 2020-04-19
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.04.020
sha: f8c527aca16595dce5672f086a30438c830f8562
doc_id: 994439
cord_uid: 32bsrr18

Abstract Objectives To better target new vaccines and treatments being developed for respiratory syncytial virus (RSV) and influenza virus (influenza), we studied the association of age with prevalence, diagnostic features and course of illness of these infections in primary care patients. Methods Secondary analysis of observational data on the aetiology, diagnosis and prognosis in adults presenting to primary care with acute cough in 12 European countries (2007-2010) using regression analyses corrected for clustering of patients within countries. Age groups were 18-59 years, 60-74 years, and 75 years and older (75+). Results Nasopharyngeal swabs for 144 (4.6%), 169 (5.4%) and 104 (3.4%) out of 3104 patients were polymerase chain reaction (PCR) positive for RSV, influenza A and influenza B, respectively. RSV-prevalence in patients 75+ (8.5%) was twice the prevalence in those under 60 years (4.2%). Influenza prevalence was not associated with age. Diagnostic features for these viruses were not associated with age. Symptom duration was associated with age for RSV and influenza B, but not for influenza A. The odds of unresolved symptoms after 28 days was associated with age for RSV only. Illness deterioration was associated with age for RSV, with patients 75+ at increased risk, but not for influenza. Conclusion In adults presenting to primary care with acute cough, the diagnostic features of RSV or influenza infection are not associated with age. For RSV both the prevalence and illness course are significantly worse at higher age, for influenza only the illness course is.

Introduction 57 Viral respiratory tract infections (RTIs) are a major public health problem due to their ease of 58 transmission, substantial morbidity and wide occurrence. Their higher incidence and severity during 59 winter months increases the burden of RTIs. Associated pathogens confined to winter months, with 60 often overlapping epidemics, are respiratory syncytial virus (RSV) and influenza virus 61 Also in individuals between the ends of the age spectrum (mostly working adults), RSV and influenza 66 are considered important pathogens (Hashem and Hall 2003; Hall et al. 2009 ). 67

With new vaccines and treatments under development, identifying phenotypic features and risk 68 groups that can be targeted with these potential vaccines and treatments for RSV and influenza is 69 becoming increasingly relevant. A promising example of targeted treatment is the use of different 70 treatment strategies across age groups. However, the association of age with prevalence, diagnostic 71 features and illness course of RSV and influenza infection in adults is not well described. Several 72 international studies reported on the prevalence of RSV among adults with cough in primary care. 73

However, these studies recruited from a single country, mostly the US (Dowell et al. 1996 course of RSV approaches that of influenza, with the elderly at higher risk of serious illness (Haber 76 Methods 82 Data 83

The data used in this study were part of the prospective GRACE (Genomics to combat Resistance 84 against Antimicrobials in Community-acquired lower respiratory tract infection (LRTI) in Europe; 85 www.grace-lrti.org) study. A detailed description of the original study can be found elsewhere (Ieven 86 et al. 2018 symptoms and additional test results, was evaluated using an HGLM. Included patient characteristics 120 were gender (male/female), current smoker (yes/no), history of pulmonary comorbidities (asthma 121 and/or chronic obstructive pulmonary disease and/or other chronic lung disease; yes/no) and history 122 of cardiac comorbidities (heart failure and/or ischemic heart disease and/or other heart disease; 123 yes/no). Selected symptoms related to RSV or influenza infection were runny nose (yes/no), fever 124 (yes/no), wheeze (yes/no) and interference with normal activities or work (yes/no). In addition, virus-125 specific association of age with the presence of pneumonia on a chest radiograph (yes/no), and 126 detection of bacteria (yes/no) and viruses (yes/no) on a NPS was assessed. 127

Virus-specific association of age with the illness course of RSV and influenza was examined after 128 exclusion of patients that did not return their diary and was defined using three outcomes: duration consultation with new or worsened complaints or admission to a hospital. Included symptoms were 131 cough, shortness of breath, wheeze, runny nose, chest pain, fever, disturbed sleep and interference 132 with normal activities or work. Duration of symptoms was defined as the number of days until the 133 patients rated their symptoms as 'no problem' (score = 0). For each symptom, virus-specific 134 association of age with duration of the symptom was studied using an accelerated failure time model 135 with Weibull distributed error terms that accounts for clustering of patients within countries. 136

Patients who were still experiencing symptoms at day 28 were labelled as patients with unresolved 137 symptoms. The odds of unresolved symptoms was compared using a Firth-adjusted HGLM for each 138 symptom (Firth 1993 

We demonstrated that the prevalence of RSV was associated with age, while the prevalence of 255 influenza was not. The diagnostic features of neither RSV nor influenza were associated with age. 256

However, whenever another virus was detected, presence of RSV or influenza was less likely. The 257 duration of symptoms of RSV and influenza A, but not influenza B, was associated with age. 258

Symptoms resolution after 28 days was associated with age for RSV, but not for influenza A. Illness 259 deterioration was associated with age for RSV, but not for influenza. prevalence, diagnostic features and illness course of RSV and influenza in adults presenting to 299 primary care with acute cough. Strengths of this study include the participation of adults from 300 different age groups across 12 European countries. A limitation is that only adults with acute cough 301 or adults suspected of an LRTI that presented to primary care were included in the study. 

Syncytial Virus and Human Rhinovirus Infection in Infancy

Healthcare resource use and economic burden attributable to 336 respiratory syncytial virus in the United States: a claims database analysis

Interference between outbreaks of respiratory syncytial virus and influenza virus infection

Surveillance of respiratory viral infections by rapid immunofluorescence diagnosis, with emphasis 341 on virus interference

Clinical Features, Severity, and Incidence of 343 RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old

Clinical Features, Severity, and Incidence of 346 RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old

Rhinoviruses 349 delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France

Important Cause of Community-Acquired Lower Respiratory Infection among Hospitalized Adults

Respiratory Syncytial Virus Infection in Elderly and 357 High-Risk Adults

Bias Reduction of Maximum Likelihood Estimates

Do rhinoviruses reduce the probability 360 of viral co-detection during acute respiratory tract infections?

Winter viruses: influenza-and respiratory 362 syncytial virus-related morbidity in chronic lung disease

Respiratory syncytial virus infection in elderly adults

Respiratory Syncytial Virus Infections in Previously Healthy Working Adults

Syncytial Virus Infection in Young Children

Respiratory syncytial virus in healthy adults: the cost of a cold

Aetiology of lower respiratory 371 tract infection in adults in primary care: a prospective study in 11 European countries

Exposure to cold and respiratory tract infections

Acute viral infections of upper respiratory tract in elderly people 376 living in the community: comparative, prospective, population based study of disease burden

The clinical features of respiratory syncytial virus: Lower respiratory 379 tract infection after upper respiratory tract infection due to influenza virus

Symptomatic Respiratory Syncytial Virus Infection 381 in Previously Healthy Young Adults Living in a Crowded Military Environment

In vitro growth profiles of respiratory syncytial virus in the 384 presence of influenza virus

Mortality associated with 386 influenza and respiratory syncytial virus in the United States

N: number of patients; IQR: interquartile range. Numbers printed in italic indicate that significance testing was not conducted because at least one of the age groups contained no variation (i.e. RSV -adjusted OR (95%CI) Influenza A -adjusted OR (95%CI) Influenza B -adjusted OR (95%CI)

OR: odds ratio; CI: (bootstrap-based) confidence interval; Numbers printed in italic report number of events/number of patients instead of odds ratios which indicates that significance testing 422 was not conducted because at least one of the age groups contained no variation (i.e. no patients with unresolved symptoms). Numbers printed in bold indicate significance: models accounted